Prof. Akiko Iwasaki
We study antiviral immunity and viral disease pathogenesis. #COVID19 #longCOVID #vaccines @HHMINEWS @YaleIBIO @YaleMed @YaleCII President of @ImmunologyAAI
عرض في 𝕏سلاسل التغريدات
Delighted to share our latest work on #longCOVID - sex differences in symptoms and immune signatures. Led by @SilvaJ_C @taka_takehiro @wood_jamie_1 et al. with @LeyingGuan & @Putri...
A while ago, @MiyuMoriyama et al showed that SARS-CoV-2 variants suppress MHC I levels in infected cells to the same degree as the ancestral virus. Then came the Omicron variants....
How does COVID reinfection happen? Our deep dive into the immune profiles during the 1st and 2nd infections. A case study. Work led by @sneakyvirus1 @AndersonBrito_ Paul Turbin...
Are you confused about the role of type I interferons (IFN) in #SARS_CoV_2 infection? Here is my speculation on what makes IFN-I helpful vs. harmful in #COVID19 patients - it com...
A first case of #COVID19 reinfection from HKU, with distinct virus genome sequences in 1st and 2nd infection (142 days apart). Kudos to the scientists for this study. This is no c...
How does the immune system work? Will there be #COVID19 vaccines? @BioRender & I put together ‘immunology 101 tweetorial for non-immunologists’. @jerryguartist, @shizaoki, @JungHee...
This is a cautionary tale of how anti-Spike antibody may make COVID disease worse. In this study, the authors show that anti-Spike IgG made SARS-CoV disease worse by switching macr...